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Abstract
Background: Polarised gene expression is thought to lead to the graded distribution of signaling
molecules providing a patterning mechanism across the embryonic eye. Bone morphogenetic
protein 4 (Bmp4) is expressed in the dorsal optic vesicle as it transforms into the optic cup. Bmp4
deletions in human and mouse result in failure of eye development, but little attempt has been made
to investigate mammalian targets of BMP4 signaling. In chick, retroviral gene overexpression studies
indicate that Bmp4 activates the dorsally expressed Tbx5 gene, which represses ventrally expressed
cVax. It is not known whether the Tbx5 related genes, Tbx2 and Tbx3, are BMP4 targets in the
mammalian retina and whether BMP4 acts at a distance from its site of expression. Although it is
established that Drosophila Dpp (homologue of vertebrate Bmp4) acts as a morphogen, there is little
evidence that BMP4 gradients are interpreted to create domains of BMP4 target gene expression
in the mouse.
Results: Our data show that the level of BMP4 signaling is critical for the regulation of distinct
Tbx2, Tbx3, Tbx5 and Vax2 gene expression domains along the dorso-ventral axis of the mouse
optic cup. BMP4 signaling gradients were manipulated in whole mouse embryo cultures during optic
cup development, by implantation of beads soaked in BMP4, or the BMP antagonist Noggin, to
provide a local signaling source. Tbx2, Tbx3 and Tbx5, showed a differential response to alterations
in the level of BMP4 along the entire dorso-ventral axis of the optic cup, suggesting that BMP4 acts
across a distance. Increased levels of BMP4 caused expansion of Tbx2 and Tbx3, but not Tbx5, into
the ventral retina and repression of the ventral marker Vax2. Conversely, Noggin abolished Tbx5
expression but only shifted Tbx2 expression dorsally. Increased levels of BMP4 signaling caused
decreased proliferation, reduced retinal volume and altered the shape of the optic cup.
Conclusion: Our findings suggest the existence of a dorsal-high, ventral-low BMP4 signaling
gradient across which distinct domains of Tbx2, Tbx3, Tbx5 and Vax2 transcription factor gene
expression are set up. Furthermore we show that the correct level of BMP4 signaling is critical for
normal growth of the mammalian embryonic eye.
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Background
Eye development begins in the fourth week of life in a
human embryo, and at embryonic day (E) 8.5 in the
mouse embryo. Bilateral protrusions of the developing
forebrain neuroepithelium extend towards the surface
ectoderm to form the optic vesicles. Invagination of the
optic vesicle together with the overlying surface ectoderm
forms the bi-layered optic cup and lens vesicle respec-
tively. The distal region of the optic vesicle gives rise to the
inner layer of the optic cup, the presumptive neural retina
(NR). The proximal region of the optic vesicle forms the
optic stalk and the outer layer of the optic cup forms the
retinal pigmented epithelium (RPE). The optic cup is ini-
tially incomplete along the ventral surface and closure of
the optic fissure marks the completion of the eye globe
[1]. By around 6 weeks of human development (E13.5 in
mouse) these critical stages of early eye morphogenesis
are accomplished [2]. If disrupted, congenital malforma-
tions of the eye, such as anophthalmia, microphthalmia,
and coloboma occur. These clinical conditions are hetero-
geneous and complex, probably involving genetic and
environmental factors, however, a number of causative
single gene mutations have been identified in humans or
in murine models [3]. Elucidation of the interactions
between key genes may lead to the identification of com-
mon pathways that are critical for the formation and
growth of the embryonic optic cup.
During the morphological transition of the optic vesicle
into the optic cup, formation of the dorsal (superior) part
of the optic cup precedes formation of the ventral (infe-
rior) part and closure of the optic fissure. As the optic cup
forms in the chick and the mouse embryos, the ventral ret-
inal region has a higher rate of proliferation compared
with the dorsal retinal region [4,5]. Recent cell lineage
tracing experiments carried out in chick embryos, using
replication defective retroviruses suggested that the dorso-
ventral (D-V) axis of the neural retina is divided into mul-
tiple domains of restricted gene expression which exhibit
features of lineage compartments, with clones of cells
originating within one compartment rarely crossing to
neighbouring compartments [6]. Thus, differential regula-
tion of cell proliferation within domains of gene expres-
sion across the D-V axis may be a mechanism driving the
formation of the globe-like structure of the optic cup. The
molecular mechanisms that pattern and shape this early
growth phase of eye development are not well under-
stood.
Signaling centres are believed to define 'patterning axes'
within developing tissues through the diffusion of signal-
ing molecules/morphogens and/or propagation of sec-
ondary relay mechanisms [7-10]. Asymmetric distribution
of several secreted signaling molecules including bone
morphogenetic protein (BMP), sonic hedgehog (SHH)
and retinoic acid (RA) are implicated in regulating the
development of the vertebrate eye [11,12]. RA signaling is
needed for normal eye morphogenesis in mouse [13,14]
and alteration of levels of RA signaling causes deletion or
duplication of the ventral zebrafish retina [15,16]. SHH
overexpression in zebrafish causes optic stalk hypertrophy
and mutation of the human SHH gene is associated with
holoprosencephaly and coloboma [17-19].
While important regulators of ventral retinal develop-
ment have been identified [11,20-23], there is less under-
standing of the requirements for dorsal regulators in
patterning and development of the dorsal retina or how
they may affect formation of the ventral eye. The studies
reported here focus on the role of Bmp4, which is specifi-
cally expressed in the dorsal retina of several vertebrate
species including the mouse [24-26].
BMPs direct D-V patterning in both invertebrate and ver-
tebrate embryos and are thought of as morphogens acting
throughout a field of cells in a graded fashion [27-29].
Decapentaplegic (Dpp), the BMP4 homologue in Dro-
sophila melanogaster has been at the forefront of morpho-
gen studies exploring how endogenous morphogen
gradients are shaped and interpreted to create boundaries
for BMP target gene expression [30-32]. In vertebrates, a
common role for BMP4 in tissue morphogenesis is emerg-
ing, notably in the limb, the mandible, and the beak [33-
37]. Variation in the pattern of Bmp4  expression was
recently shown to affect the shape and size of closely
related finch beaks originally described by Darwin; Bmp4
misexpression in chick embryos, causes morphological
transformations paralleling the beak morphology of the
large ground finch [36,38].
BMP action in the nervous system includes effects on neu-
ral induction, cell fate determination, apoptosis and pro-
liferation [39]. In the chick retina, Bmp4  has been
implicated in regulating programmed cell death in the
dorsal optic cup [40] and in regulating topographic map-
ping of retinal ganglion cells [41]. Overexpression of the
BMP antagonist, Noggin, in chick, induces microphthal-
mia and coloboma, together with other ventral abnormal-
ities, suggesting that endogenous BMPs have significant
effects on the development of ventral optic cup structures
[42]. Experiments in which optic vesicle explant cultures
from  Bmp4  null mice were treated with BMP4-soaked
beads have shown that BMP4 signaling is essential, but
not sufficient, for lens formation [26]. Bmp4 null embryos
die at midgestation and optic vesicle development is
arrested, hampering direct analysis of the role of Bmp4 in
optic cup development. In Bmp4+/- mice, the optic cup
forms, but mature eyes show anterior segment abnormal-
ities as well as an increased incidence of microphthalmia
[43,44]. Deletions of human chromosome 14q, includingBMC Developmental Biology 2006, 6:62 http://www.biomedcentral.com/1471-213X/6/62
Page 3 of 22
(page number not for citation purposes)
the BMP4 gene have been identified in patients with ano-
phthalmia [45-48].
Candidate downstream targets of BMP4 signaling in the
mouse retina include members of the evolutionarily con-
served T-box gene family of transcription factors. In Dro-
sophila, Dpp regulates omb, a T-box gene critical for
development of the fly visual system [31,49]. We have
previously characterised the expression of three omb-
related genes of the Tbx2 subfamily, Tbx2, Tbx3, and Tbx5
to be dorsally restricted in the human and mouse optic
cup [50]. These genes are closely related and likely evolved
from an ancestral Tbx2/omb gene via an unequal recombi-
nation event, followed by gene duplication, prior to the
divergence of the invertebrate and vertebrate lineages
[51]. Several studies in other species also support the idea
that Tbx2 subfamily genes are regulated by BMP4. Bmp4
overexpression by electroporation in chick and Xenopus
embryos induces ectopic Tbx5  expression in the retina
[41,52]. In the chick, Tbx3 expression in the limb is also
dependent on BMP signaling [53,54]. There is not yet
functional evidence for the importance of the Tbx2 sub-
family genes in mammalian eye development, however
misexpression of Tbx5 in chick embryos, perturbs retino-
tectal projections [41]. Recent work has also shown that
Tbx2b (tbx-c) in zebrafish may be important specifically
for differentiation of retinal neurons in the dorsal retina
[55].
Here we have developed the use of whole mouse embryo
culture to test the hypothesis that BMP4 signaling regu-
lates T-box gene expression in the developing mouse eye.
This is the first time that implantation of growth factor
soaked beads have been used to examine patterning of the
developing mouse eye in vivo. We examined whether per-
turbation of BMP4 levels affect optic cup growth and
shape. We report that Tbx2, Tbx3, and Tbx5 are all respon-
sive to manipulations of BMP4 signaling, but that each
gene responds differently. We found that increasing BMP4
signaling by addition of exogenous BMP4 alters the
molecular patterns of gene expression across the D-V axis
in a ventral shift, while addition of the BMP antagonist,
Noggin induces a dorsal shift. These changes in gene
expression are associated with a reduced retinal volume,
primarily due to reduced cell proliferation and alterations
in the axial lengths of the optic cup, indicating that correct
levels of BMP signaling are important for the growth and
the shape of the embryonic eye.
Results
Nested expression of Bmp4, Tbx2, Tbx3 and Tbx5 in the 
mouse optic cup
The expression pattern of Bmp4 and members of the Tbx2
subfamily were compared during development of the
optic cup in mouse embryos. Bmp4  expression was
detected in the dorso-distal optic vesicle from E9.5 (Fig.
1A, somite stage 15) in the region of neuroepithelium
contacting the surface ectoderm. The distal optic vesicle is
the presumptive neural retina. Tbx5  and  Tbx2  were
expressed in a similar region of the presumptive neural
retina as Bmp4 at this stage (Fig. 1B,C). Bmp4 and Tbx2,
but not Tbx5 were expressed in the mesenchyme ventral to
the optic vesicle (white arrowheads in Fig. 1A and 1C).
Bmp4 was also expressed in the surface ectoderm (Fig. 1A,
black arrowhead), as previously reported [26].
During optic cup invagination at E10.5, the Bmp4 expres-
sion domain in the dorsal neural retina remained similar
to that of Tbx5 and Tbx2 (Fig. 1D,E,F). By E11.5, Tbx5 and
Bmp4 were co-expressed in the dorsal-most region of the
optic cup, designated domain 1 (Fig. 1G–J), whereas Tbx2
expression in the dorsal retina was broader and extended
ventrally beyond domain 1 into a second domain desig-
nated domain 2 (Fig. 1L,M). A third Tbx2 subfamily gene,
Tbx3, was also expressed in domain 1 and extended into
domain 2 in the temporal, but not nasal, neural retina
(Fig. 1K,N). Tbx2, Tbx3 and Bmp4 were also expressed in
the mandibular and maxillary processes, ventral to the
optic cup (Fig. 1G,K,L). Expression domains 1 and 2, were
compared with the expression domain of a ventral
marker, the Vax2 homeobox gene. Vax2 is expressed in the
ventral-most region, designated domain 4 (Fig. 1O). The
region lying between domains 2 and 4, which expresses
neither Tbx2, nor Vax2, was designated domain 3 (Fig.
1P–R).
Bmp4 is thus highly expressed within the dorso-distal eye
primordia, providing a dorsal source of BMP4 signaling
throughout formation of the optic cup. The spatio-tempo-
ral overlap in the expression patterns of Bmp4, Tbx2, Tbx3
and Tbx5 in the dorsal eye supports the idea that BMP4 is
an upstream regulator of these Tbx2 subfamily genes dur-
ing mouse eye development. That Tbx2  and  Tbx3  are
expressed in a broader domain than Bmp4, suggests that
these genes may respond to BMP4 signaling which is act-
ing some distance from the source of Bmp4 expression. To
test the hypothesis that Bmp4 expressed in domain 1, reg-
ulates T-box gene expression in domains 1 and 2, we
aimed to increase the level of BMP4 signaling by implant-
ing growth factor soaked agarose beads into the mouse
eye primordia and then observed the effect on gene
expression domains.
We developed a system using whole mouse embryo cul-
ture, analogous to the method of bead implantation used
in the developing chick embryo in ovo [56,57]. In contrast
to widespread retroviral or plasmid overexpression
approaches, growth factor soaked beads allow the estab-
lishment of a local signaling source to test the effect of dif-
fusion of signaling factors across a field of cells. MouseBMC Developmental Biology 2006, 6:62 http://www.biomedcentral.com/1471-213X/6/62
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Expression of Bmp4, Tbx2, Tbx3, Tbx5, and Vax2 during optic cup formation Figure 1
Expression of Bmp4, Tbx2, Tbx3, Tbx5, and Vax2 during optic cup formation. (A-C) Bmp4 co-expressed with Tbx5 
and Tbx2 in the optic vesicle at E9.5 (arrows; 15 somite stage). Black arrowhead in A indicates Bmp4 expression in the surface 
ectoderm. White arrowheads indicate expression in mesenchyme ventral to the developing eye. (D-F) Bmp4, Tbx5 and Tbx2 
expression in the invaginating optic vesicle at E10.5 (24–29 somite stage). (G, H) Bmp4 and Tbx5 expression at E11.5 in the 
optic cup in dorsal domain 1, shown schematically in I. (J) Tbx5 expression in dorsal domain 1 in an E11.5 dissected optic cup. 
(K) Tbx3 expression in dorsal domain 1 and its extension into dorsal domain 2 in the temporal neural retina. (L) Tbx2 expres-
sion in domains 1 and 2, shown schematically in M. (N) Tbx3 expression in an E11.5 dissected optic cup. (O) Vax2 expression 
at E11.5 in the ventral optic cup in domain 4. (P) Double labeling of Tbx2 (red) and Vax2 (blue) shows a domain in between 
domain 2 and domain 4, which does not express either marker, and is designated domain 3, shown schematically in Q. (R) 
Tbx2 (red) and Vax2 (blue) expression in an E11.5 dissected optic cup, revealing domain 3 in white. Arrows in G-R indicate the 
boundaries of gene expression domains. Dashed circles in J, N, R demarcate the lens vesicle. A-F are coronal sections. Scale 
bars: A-F, 0.05 mm; G, H, K, L, O, P, 0.5 mm; J, N, R, 0.1 mm. Abbreviations: L, lens placode; MN, mandibular process of the 
first branchial arch; NR, neural retina; P-NR, presumptive neural retina; D-V indicates the dorso-ventral axis, N-T indicates the 
naso-temporal axis.BMC Developmental Biology 2006, 6:62 http://www.biomedcentral.com/1471-213X/6/62
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embryos were cultured using established conditions [58].
Control experiments were performed to ensure, first, that
normal optic cup morphogenesis was achieved, and sec-
ond, that implantation of beads soaked in the biologically
inactive protein, bovine serum albumin (BSA), did not
disrupt normal morphogenesis or gene expression. We
found that normal eye development occurred ex utero dur-
ing whole mouse embryo culture; embryos were cultured
from three time points: E9.5 (optic vesicle); E10.5 (optic
vesicle to optic cup transition); and E11.5 (early optic
cup). In CBA/Ca embryos, optic vesicle invagination initi-
ates at 24–26 somites and the optic cup forms by late
E10.5, at 33–35 somites. This process occurred faithfully
in culture (Fig. 2A–C, pre-culture optic vesicle, Fig. 2D–H
post-culture optic cup compare with Fig. 2D'–H' stage
matched non-cultured optic cup). Normal growth and
pigmentation of the optic cup also occurred in culture
(Fig. 2N–S post-culture optic cup compare to Fig. 2N'–S'
stage matched non-cultured optic cup) and normal pat-
terns of T-box gene expression were observed in post-cul-
ture embryos (Fig. 2 and data not shown). Implantation
of BSA-soaked agarose beads around the optic vesicle and
within the lens of the optic cup did not disrupt morpho-
genesis or gene expression (Fig. 2I–M and data not
shown). Hence, embryo culture, combined with bead
implantation provides a useful ex utero model for investi-
gation of how alteration of BMP signaling affects pattern-
ing of the mammalian optic cup.
Exogenous BMP4 induces T-box gene expression in the 
developing optic cup
BMP4-soaked beads were implanted in the dorso-tempo-
ral or dorso-nasal peri-ocular mesenchyme adjacent to the
optic vesicle of E9.5 and E10.5 embryos, which were cul-
tured overnight. Beads soaked in recombinant BMP4 pro-
tein have previously been shown to be functionally active
in the mouse embryo [26]. The bead implantation site
was selected to provide an ectopic source of BMP4 signal-
ing, and the effect of growth factor perturbation in the
operated eye was compared to the contralateral non-
treated eye in each embryo.
Exogenous BMP4 induced ectopic Tbx2 and Tbx5 expres-
sion in the proximal optic vesicle, the presumptive RPE
(Table 1; Fig. 3A–F). The extension of the normal expres-
sion domain is visible in dorsal views of the embryos (Fig.
3A,B). Transverse sections showed Tbx2 and Tbx5 up-reg-
ulation in the presumptive RPE that normally does not
express the T-box genes, with Tbx2  showing the most
marked response (Fig. 3C,D). On the non-treated side, as
well as in control embryos implanted with BSA-soaked
beads, T-box gene expression was restricted to the dorso-
distal optic vesicle (Fig. 3A,B,E,F and data not shown).
To assess the effect of changing the level of BMP4 signal-
ing during optic cup formation, BMP4-soaked beads were
implanted adjacent to the optic vesicle of early E10.5 (22–
26 somites) embryos, prior to optic vesicle invagination,
and embryos were cultured through the invagination
process. Tbx5 expression was never extended to the ventral
retina and remained dorsally restricted (Fig. 3G,H). Sec-
tions through the dorsal eye showed that Tbx5  was
induced in the presumptive RPE adjacent to the bead, con-
sistent with observations at E9.5 (Fig. 3I,J). Rarely, exoge-
nous BMP4 extended Tbx2 expression into domain 3 in
the ventral retina (Table 1; Fig. 3K–N). No change in
expression of Vax2 or Tbx3 was observed after BMP4 bead
implantation (Table 1). BMP4-soaked beads placed tem-
poral to the eye gave similar results to nasal implantation
(nasal data are shown in Table 1).
Tbx2 and Tbx5 could not be induced in the ventral-most
region, domain 4, even when BMP4-soaked beads were
placed ventral to the optic vesicle in E9.5 and E10.5 cul-
ture (data not shown). Exogenous BMP4 did not disrupt
the process of optic vesicle invagination; normal optic cup
formation occurred during the culture period. In sum-
mary, exogenous BMP4 protein induced ectopic expres-
sion of both Tbx2 and Tbx5 during optic cup formation.
Noggin abolishes Tbx5 and reduces Tbx2 expression
To provide further evidence supporting the role of BMP4
signaling in regulating T-box gene expression, we used the
BMP antagonist, Noggin, to block BMP4 signaling in the
eye (Fig. 4). Noggin has high affinity for BMP4 and pre-
vents BMP receptor-ligand association, hence disrupting
the signaling pathway [59].
Noggin-soaked beads were implanted close to the site of
endogenous Bmp4 expression, dorsal to the optic vesicle
of E10.5 embryos. Noggin abolished Tbx5 expression (Fig.
4A,B,A',B'), but only reduced the Tbx2 expression domain
to the dorsal-most region of the eye, domain 1, and did
not markedly affect Tbx3 expression (Fig. 4C,D,C',D' and
[see Additional File 1A, B]; Table 1). Implantation of BSA-
soaked beads in the same position as the Noggin-soaked
beads had no effect on either Tbx5 or Tbx2 expression (Fig.
4E–H,E'–H'). Analysis of Vax2  after Noggin treatment
showed that Vax2 expression was maintained ([see Addi-
tional File 1C, D]; Table 1).
Analysis of the morphology of manipulated eyes revealed
that dorsal optic vesicle invagination initiated in the pres-
ence of Noggin. However, the ventral region of the oper-
ated eye, showed a marked delay in the invagination
process (Fig. 4M–P) when compared to the contralateral
control eye (Fig. 4I–L; n = 6/8). In operated eyes, invagi-
nation to form the optic cup had not occurred in ventral
sections, and only the single layered neuroepithelium ofBMC Developmental Biology 2006, 6:62 http://www.biomedcentral.com/1471-213X/6/62
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Optic cup development in whole mouse embryo culture Figure 2
Optic cup development in whole mouse embryo culture. A-S' are serial transverse sections through the developing 
optic vesicle and optic cup, ordered with dorsal (D) sections uppermost. A-H, I-M, and N-S show Tbx5 expression (in blue). 
(A-C) E10.5 optic vesicle (not cultured). (D-H) Post-culture early optic cup. Compare with A-C for pre-culture stage of 
development and to D'-H' for a stage matched non-cultured optic cup. Invagination to form an optic cup with a thick neural 
retina (NR) surrounded by a thin layer of presumptive retinal pigmented epithelium (RPE), and formation of a lens vesicle (L) 
occur normally during culture. (I-M) Post-culture optic cup implanted with a control bead, showing normal eye morphology 
and gene expression. (N-S) Post-culture late optic cup. Compare with D'-H' for the approximate pre-culture stage of develop-
ment and with N'-S' for the non-cultured stage matched equivalent. Growth of the NR, pigmentation of the RPE, and apposi-
tion of the optic fissure walls (indicated by arrows in S and S') proceed normally during culture. Scale bars: 0.1 mm. 
Abbreviations: D, dorsal; L, lens vesicle; NR, neural retina; P-NR; presumptive neural retina; OF, optic fissure; OS, optic stalk; 
RPE, retinal pigmented epithelium; P-RPE, presumptive RPE; ss, somite stage; V, ventral.BMC Developmental Biology 2006, 6:62 http://www.biomedcentral.com/1471-213X/6/62
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the optic vesicle was observed (Fig. 4N–P), By contrast,
formation of the bi-layered optic cup and increased
growth of the presumptive neural retina was advanced in
the ventral region of control eyes (Fig. 4J–L).
In summary, at E10.5, Noggin-soaked beads induced a
dorsal shift in expression domains by repressing expres-
sion of Tbx5 in domain 1 and Tbx2 in domain 2. Thus, the
dorsal-most region of the retina acquired the expression
profile of domain 2, in that it was Tbx2-positive, Tbx5-neg-
ative (Fig. 4Q). Although Tbx2 and Tbx5 expression was
altered by increased or decreased levels of BMP4 signaling
, Tbx3 and Vax2 expression appeared tolerant of the same
changes in BMP signaling levels.
Effect of disruption of BMP4 signaling on dorso-ventral 
patterning
To explore whether the concentration of BMP4 is impor-
tant for defining distinct domains of gene expression in
the mouse optic cup, and whether genes show different
responses to alterations in the level of signaling, BMP4-
soaked beads were placed centrally in the eye, within the
lens vesicle of optic cup stage E11.5 embryos. Exogenous
BMP4 added to the centre of the optic cup is at an equiv-
alent distance from both the dorsal and the ventral retina,
and by raising BMP4 levels throughout the eye, may dis-
rupt the normal putative BMP4 (dorsal-high, ventral-low)
signaling gradient.
Exogenous BMP4 resulted in the extension of Tbx5 expres-
sion from domain 1 across the dorsal half of the retina,
covering the normal site of Tbx2 expression in domain 2
(Table 1; Fig. 5A,B). Ectopic Tbx5 expression never crossed
to the ventral half of the retina. Tbx2 was expanded into
the ventral retina to cover domain 3 (Fig. 5C,D), and Tbx3
was expanded across domains 2, 3 and 4 (Fig. 5E,F). Strik-
ingly,Vax2 expression in domain 4, was completely abol-
ished in BMP4-treated eyes (Fig. 5G,H). Tbx2, but not
Tbx3 or Tbx5, was also induced in the lens (which does not
normally express Bmp4; Fig. 5C,D). Double in situ hybrid-
isation for Tbx2  and Vax2 confirmed the expansion of
Tbx2 to entirely cover domain 3, but not 4, and the loss of
Vax2 in domain 4 (Fig. 5I–N). Control experiments, car-
ried out by implantation of BSA-soaked beads in the same
location as BMP4-soaked beads either in the contralateral
eye of the same embryo, or in parallel on somite-matched
embryos never showed alterations in patterns of gene
expression (Fig. 5C,E,G,I; Table 1, and data not shown).
Our findings show that exogenous BMP4 provided to the
central region of the eye has shifted the normal gene
expression boundaries ventrally by one or more domains
(Fig. 5O), suggesting that the molecular division of the
retina into gene expression domains is dependent on pre-
cise levels of BMP4 signaling. Although all genes showed
a ventral shift, their response was non-uniform suggesting
that additional regulatory mechanisms exist. Domain 1
Table 1: Changes in gene expression by BMP4, Noggin, and BSA-soaked beads at E9.5-E11.5
Protein Stage Gene Gene expression altered
BMP4 E11.5 (bead in lens) Tbx5 10/12 (+)
Tbx2 11/13 (+)
Tbx3 3/3 (+)
Vax2 4/4 (-)
E10.5 (bead in mes) Tbx5 3/8 (+)
Tbx2 1/4 (+)
Tbx3 0/2
Vax2 0/2
E9.5 (bead in mes) Tbx5 3/3 (+)
Tbx2 2/2 (+)
BSA E11.5 (bead in lens) Tbx5 0/5
Tbx2 0/6
Tbx3 0/1
Vax2 0/6
E10.5 (bead in mes) Tbx5 0/3
Tbx2 0/2
E9.5 (bead in mes) Tbx5 0/2
Noggin E10.5 (bead in mes) Tbx5 6/6 (-)
Tbx2 4/4 (-)
Tbx3 0/2
Vax2 0/3
Mes, mesenchyme; Altered gene expression after culture with bead: + indicates induction; - indicates repression. Bead implantation was into nasal 
peri-ocular mesenchyme.BMC Developmental Biology 2006, 6:62 http://www.biomedcentral.com/1471-213X/6/62
Page 8 of 22
(page number not for citation purposes)
Induction of Tbx2 and Tbx5 expression by exogenous BMP4 Figure 3
Induction of Tbx2 and Tbx5 expression by exogenous BMP4. (A, B) Dorsal views of post-culture embryos showing 
ectopic expression of Tbx2 (A) and Tbx5 (B) in the proximal optic vesicle (arrowheads) after implantation of a BMP4-soaked 
bead in the peri-ocular mesenchyme (asterisks). Expression is extended into the presumptive RPE on the treated side but 
restricted to the presumptive neural retina on the contralateral non-treated side shown by transverse sections through the 
optic vesicle (arrowheads,C-F). (G, H) Lateral views of a post-culture embryo showing normal Tbx5 expression in the non-
treated eye (G) and increased Tbx5 expression after implantation of a BMP4-soaked bead in the periocular mesenchyme (H). 
Arrows demarcate the Tbx5 expression domain. (I-J) Transverse sections of the non-treated and BMP4-treated contralateral 
eyes showing the extended Tbx5 expression into the presumptive RPE next to the BMP4-soaked bead (arrow). (K-N) Serial 
transverse sections showing normal Tbx2 expression in a control eye (K, M) and the extension of Tbx2 expression ventrally 
after implantation of a BMP4-soaked bead in the treated eye (L, N). Sections M and N are immediately ventral to sections K 
and L. Scale bars: A, B, 0.1 mm; C-F, 0.05 mm; G, H, 0.5 mm; I-N, 0.1 mm. Abbreviations: L, lens vesicle; MN, mandibular region 
of the first branchial arch; MX, maxillary region of the first branchial arch; N, nasal; NR, neural retina; P-NR, presumptive neu-
ral retina; OS, optic stalk; P-RPE, presumptive retinal pigmented epithelium; T, temporal.BMC Developmental Biology 2006, 6:62 http://www.biomedcentral.com/1471-213X/6/62
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Repression of Tbx2 and Tbx5 expression by exogenous Noggin Figure 4
Repression of Tbx2 and Tbx5 expression by exogenous Noggin. (A) Post-culture embryo showing Tbx5 expression in 
the non-treated dorsal optic cup. (B) Contralateral Noggin-treated eye, showing absence of Tbx5 expression in the optic cup. 
(C) Post-culture embryo showing Tbx2 expression in the non-treated dorsal optic cup. (D) Contralateral Noggin-treated eye 
showing a reduced Tbx2 expression domain. Tbx5 expression (E, F) and Tbx2 expression (G, H) are not altered in non-oper-
ated and BSA-treated eyes respectively of post-culture embryos. A'-H' show higher magnifications of eyes in A-H. Arrows indi-
cate boundaries of gene expression domains. Implanted beads are marked by asterisks. (I-P) Serial transverse vibratome 
sections through the optic cup showing altered morphology after Noggin treatment, with the dorsal-most sections in upper 
panels. (I-L) Post-culture non-treated eye showing invagination of the presumptive neural retina (P-NR) in the ventral optic 
cup. (M-P) Contralateral Noggin-treated eye showing dorsal extension of the optic stalk region as compared to the non-
treated eye. (Q) Schematic representation of normal Tbx2 and Tbx5 expression domains in a lateral view of the optic cup, and 
the dorsal shift of the expression domains induced by exogenous Noggin. Scale bars: A-H, 0.5 mm; I-P, 0.1 mm. Abbreviations; 
MN, mandibular process of the first branchial arch; MX, maxillary process of the first branchial arch; N, nasal process; P-NR, 
presumptive neural retina; OS, optic stalk.BMC Developmental Biology 2006, 6:62 http://www.biomedcentral.com/1471-213X/6/62
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Ventral shift of gene expression along the D-V axis of the optic cup after BMP4 treatment Figure 5
Ventral shift of gene expression along the D-V axis of the optic cup after BMP4 treatment. Beads are indicated 
with asterisks and domains of gene expression are demarcated with arrows. (A) Post-culture embryo showing normal dorsal 
Tbx5 expression in the control optic cup. (B) Contralateral BMP4-treated eye, showing extension of the Tbx5 expression 
domain. (C) Post-culture embryo showing normal dorsal Tbx2 expression in the control BSA-treated optic cup. (D) Contral-
ateral BMP4-treated eye, showing extension of the Tbx2 expression domain into the ventral optic cup and induction of expres-
sion in the lens. (E) Post-culture embryo showing normal dorsal Tbx3 expression in the control BSA-treated optic cup. (F) 
Contralateral BMP4-treated eye, showing induction of Tbx3 expression throughout the ventral optic cup. (G) Post-culture 
embryo showing normal ventral expression of Vax2 in the control BSA-treated optic cup. (H) Contralateral BMP4-treated eye, 
showing complete absence of Vax2 expression. (I, J) Double in situ hybridisation of Tbx2 expression (red) and Vax2 expression 
(blue) in control BSA-treated (I) and contralateral BMP4-treated eyes (J). (K-N) Transverse sections through the planes indi-
cated in I and J, showing induction of ectopic Tbx2 expression (K, L) and repression of Vax2 expression (M, N) upon BMP4 
treatment. (O) Schematic representation of gene expression domains 1–4 along the D-V axis of the whole mount optic cup 
and the ventral shift of domains upon BMP4 treatment. Domain 3* is Tbx2-negative, Tbx3-positive, Vax2-negative. Scale bars: A-
J, 0.5 mm; K-N, 0.1 mm. Abbreviations: L, lens vesicle; MN, mandibular process of the first branchial arch; MX, maxillary proc-
ess of the first branchial arch; NR, neural retina.BMC Developmental Biology 2006, 6:62 http://www.biomedcentral.com/1471-213X/6/62
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(Tbx5-positive, Tbx2-positive), was expanded ventrally to
cover the former site of the Tbx5-negative, Tbx2-positive
domain 2; whereas the latter domain is now shifted to the
more ventral former site of domain 3. Tbx3 showed a dif-
ferent response and shifted ventrally by two domains into
the entire ventral retina. Domain 3*, which shows the
expression profile Tbx5-negative, Tbx2-negative, Tbx3-pos-
itive is in the ventral-most region of BMP4-treated eyes
and the Vax2-positive domain 4 is lost in this ventral shift-
ing of expression domains.
To assess BMP signaling in the optic cup we performed
immunohistochemistry for the Phospho-Smad 1/5/8 pro-
teins which transduce the extracellular BMP signal to the
nucleus [60]. Phospho-Smad 1/5/8 labeling was highest
in the dorsal retina (consistent with a previous report
[61]), and in the lens in non-treated control eyes, while
labeling was detected across a wider region in the retina of
BMP4-treated eyes [see Additional File 1F–I]. These data
suggest that BMP signaling in the retina extends beyond
the Bmp4 expression domain upon addition of exogenous
BMP4 [see Additional File 1E–I]. BMP4 has previously
been shown to upregulate the Msx2 homeobox gene in
other systems [62-64]. Since Msx2  is expressed in the
mouse optic cup [65] we tested the effect of BMP4 bead
implantation and compared the Msx2 response to that of
the Tbx2 subfamily genes. Exogenous BMP4 induced
Msx2 gene expression in a different pattern to any of the
other marker genes tested; high level ectopic Msx2 expres-
sion was detected in the lens, optic cup and surface ecto-
derm, as compared with control eyes [see Additional File
1J, K].
Change in eye size and shape after BMP4 treatment
BMP4-treated eyes of E11.5 embryos, displaying a ventral
shift in Tbx2 subfamily gene expression domains, were
examined for morphological abnormalities. These eyes
appeared smaller in size and this difference was analysed
by estimating retinal volumes. Retina from BMP4-treated
eyes were consistently smaller than those of contralateral
eyes treated with BSA control beads (n = 4 embryos; mean
volume ± 1 S.D., BMP4-treated retina = 7.35 × 10-3 mm3 ±
2.3 × 10-3; mean volume ± 1 S.D., BSA-treated retina =
10.90 × 10-3 mm3 ± 1.95 × 10-3; p = 0.033; Fig. 6A).
We next investigated how the eye had changed in shape,
and whether there was a change in the axial lengths of the
optic cup associated with the changed gene expression
patterns. For each embryo, the D-V, naso-temporal (N-T)
and proximo-distal (P-Di) axes of the BMP4-treated eye
were measured and compared to the control eye of the
same embryo. The percentage change in axial length
between treated and contralateral control eyes were calcu-
lated (Table 2). In the BMP4-treated group, the D-V axis of
the BMP4-treated eye was smaller than the non-treated
contralateral eye in every case (n = 25, P < 0.0001). By
contrast there was no significant difference between BSA-
treated eyes and the non-treated control (n = 8; p = 0.07).
Neither was there a significant natural variance between
the axial length of right and left eyes of non-treated cul-
tured embryos (n = 10; p = 0.10).
Similarly, the N-T axis of BMP4-treated eyes was reduced,
although the reduction along the N-T axis of BMP4-
treated eyes was less pronounced than that along the D-V
axis (Table 2, n = 25; p = 0.001). There was no significant
difference in the BSA-treated group (n = 8, p = 0.15), nor
in non-treated cultured embryos (n = 10, p = 1). By con-
trast, the P-Di axis (from the ventricular edge of the retina
to the surface ectoderm) was unchanged by the exogenous
BMP4 (n = 4, 0.58).
These data show that the addition of exogenous BMP4
reduced optic cup size and the D-V and N-T axial lengths,
though not the P-Di axial length, thus inducing a change
in the size and the shape of the optic cup. Histological sec-
tions also showed the small eye size and the abnormally
thin neural retina of BMP4-treated optic cups (Fig. 6B,C).
Cell proliferation and cell death in BMP4-treated eyes
The differences in gene expression domains and optic cup
size/shape observed after the addition of exogenous
BMP4 to developing optic cups could be due to regional
decreases in retinal cell proliferation or increases in apop-
tosis (or both). To establish whether the altered gene
expression domains correlated with regionalised changes
in cell proliferation, retinal sections were immuno-
labelled using the pH3 antibody, which labels mitotic
cells in the retina at the ventricular surface. BMP4-treated
embryos (n = 4) were examined for differences in the
number of pH3-positive cells either throughout the retina,
or in the dorsal region (containing domains 1 to 3) and
the ventral region (containing domain 4). There was a sig-
nificant overall decrease in the mitotic index (number of
pH3-labelled cells as a percentage of total cells) in BMP4-
treated compared with contralateral non-treated eyes in
cultured embryos (p = 0.005, 2-way ANCOVA, n = 30 sec-
tions; Fig. 7A–C). Comparisons of both dorsal and ventral
cell counts between eyes showed that the number of pH3-
labelled cells were significantly reduced after BMP4 treat-
ment in both the dorsal (p = 0.007; 2-way ANOVA, n = 44
sections) and the ventral (p = 0.018; 2-way ANOVA, n =
44 sections) retina [see Additional File 2A, B]. Non-treated
eyes showed a significantly higher level of mitosis (pH3
per mm2) in the ventral retina, compared to the dorsal
region (p = 0.013; 2-way ANOVA, n = 19 sections, data
not shown), but this difference was abolished in BMP4-
treated eyes (p = 0.4, data not shown).BMC Developmental Biology 2006, 6:62 http://www.biomedcentral.com/1471-213X/6/62
Page 12 of 22
(page number not for citation purposes)
Effect of BMP4 treatment on eye size and shape Figure 6
Effect of BMP4 treatment on eye size and shape. (A) Retinal volume in BMP4-treated and contralateral BSA-treated 
eyes estimated from four post-culture embryos and represented by bar charts as mean ± 1 S.D. p = 0.033 by the paired t-test 
indicates a significant reduction in retinal volume in BMP4-treated eyes. (B, C) Coronal sections of control (B) and contralat-
eral BMP4-treated (C) eyes stained with H&E and showing a reduction in eye size and retinal thickness upon BMP4-treatment. 
Scale bars: 0.05 mm.BMC Developmental Biology 2006, 6:62 http://www.biomedcentral.com/1471-213X/6/62
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Finally we used TUNEL labeling to assess whether the
altered gene expression domains observed after BMP4
treatment were associated with increased or altered pat-
terns of apoptosis. Regionalised apoptosis could cause tis-
sue ablation and loss of gene expression domains. For
example ablation of ventral tissue could cause loss of the
Vax4 expression domain and reduction of eye size. BMP4
has been shown to promote apoptosis in other systems
[57,62,66,67].
In control eyes, TUNEL labeling was detected in the region
of the optic disc and the optic stalk. Occasionally, a few
apoptotic cells were detected in the dorsal aspect of the
retina (not shown). This low level pattern of cell death
correlates well with previous reports of cell death in E11.5
mouse embryos [40]. Levels of TUNEL-labelled cells were
compared in BMP4-treated and contralateral control eyes.
No significant differences in apoptosis were detected in
the ventral (domain 4-containing) or the central retina
between BMP4-treated and control eyes, suggesting that
loss of Vax2 expression was not associated with apoptosis
(Fig. 7D,E). Instead, more TUNEL-positive cells were
found at the vitreal edge in the dorsal retina (domain 1;
Fig. 7D,E), close to the source of endogenous BMP4
expression and where BMP4 levels appear highest after
exogenous BMP4 addition. In total, 79 TUNEL-positive
cells were detected in the dorsal region of BMP4-treated
retina compared with 26 in contralateral non-treated eyes
(n = 26 sections from 5 embryos; TUNEL-positive cells: p
= 0.036 by 2-way ANOVA; TUNEL index: p = 0.04 by
ANCOVA; [see Additional File 2C]). We also carried out
BMP4-bead implantations using higher doses of BMP4 to
test whether this increased the level of apoptosis. Wide-
spread apoptosis and tissue ablation were detected
throughout the neural retina (Fig. 7G). Therefore, while
excess BMP4 can induce widespread apoptosis in the ret-
ina, the level of BMP4 that caused ventral shifts of gene
expression domains, was only associated with a modest
increase in apoptosis in the dorsal eye.
Taken together these data support the view that BMP4 sig-
naling from the dorsal eye primordia is important for
defining gene expression domains across the D-V axis of
the retina. An increase in the level of BMP4 in the optic
cup causes a shift in gene expression domains and
expands the dorsal retinal territory at the expense of the
ventral territories. These changes in gene expression
domains fundamentally alter the molecular character of
the optic cup. Furthermore, these data suggest that altera-
tions in the BMP4 signaling gradient disrupt differential
regulation of cell proliferation across the D-V axis, thus
affecting growth and shape of the optic cup.
Discussion
Using whole embryo culture and bead implantation, our
analyses have provided new evidence for the critical
importance of the level of BMP4 signaling for D-V pattern-
ing and growth of the developing mouse eye. Our data
suggest that BMP4 patterns the optic cup by dosage
dependent regulation of target genes, Tbx2, Tbx3 and Tbx5.
A conserved genetic pathway: BMP4 regulation of Tbx2 
subfamily genes
In whole embryo culture experiments, exogenous BMP4
induced Tbx2, Tbx3 and Tbx5 expression, while Noggin
repressed/reduced Tbx2 and Tbx5 expression in the devel-
oping retina, providing strong support for the idea that
BMP4 signaling regulates T-box gene expression during
mouse eye development. This is the first demonstration
that all three members of the Tbx2 subfamily, Tbx2, Tbx3
and Tbx5 genes are downstream targets of BMP signaling
in the mouse eye. A recent paper reported loss of Tbx5
expression in the optic vesicles of Bmp4-/- mice [61]. Previ-
ous reports have demonstrated BMP2/4/Dpp regulation
of Tbx2 subfamily genes in the heart, limb and retina in
other vertebrates and of omb  in  Drosophila  [41,49,52-
54,68]. Considered together, these data indicate that
BMP2/4 regulation of Tbx2 subfamily genes is an ancient
and evolutionarily conserved pathway, which has been
Table 2: Changes in axial length of the optic cup after BMP4 treatment
Treatment Group n. Mean percentage
difference ± 1.S.D.
P-value
D-V axial length none 10 98.1% ± 3.50 0.11
BMP4 25 92.33% ± 3.83 <0.0001
BSA 8 95.26% ± 7.77 0.07
N-T axial length none 10 99.97% ± 2.92 1
BMP4 25 96.66% ± 4.93 0.001
BSA 8 97.87% ± 3.50 0.15
P-Di axial length BMP4/BSA 4 93.8% ± 6.9 0.58
100% indicates no change; D-V, dorso-ventral; N-T, naso-temporal; P-Di, proximo-distalBMC Developmental Biology 2006, 6:62 http://www.biomedcentral.com/1471-213X/6/62
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Effect of BMP4 treatment on proliferation and cell death Figure 7
Effect of BMP4 treatment on proliferation and cell death. (A, B) pH3-positive cells (green) in retinal sections of con-
trol and BMP4-treated contralateral eyes of a post-culture embryo. Sections are counterstained with propidium iodide (red). 
(C) Graph showing the mitotic index per section per eye in BMP4-treated optic cups, compared with contralateral control 
optic cups (n = 30 sections from 4 embryos; p = 0.005 by ANCOVA). Data was Ln transformed for normalisation. Between 
embryo variability likely reflects the differences in growth rate of individual embryos. (D, E) Increased dorsal apoptosis 
detected by the TUNEL assay (green) in BMP4-treated eyes (arrow in E) compared to contralateral control eyes (D) of post-
culture embryos. (F, G) Apoptosis detected in eyes of post-culture embryos after high dose BMP4 treatment. Widespread 
apoptosis detected throughout the neural retina. Scale bars: 0.1 mm. Abbreviations: D, dorsal; L, lens vesicle; NR, neural retina; 
pH3, phospho-histone H3; TUNEL, Terminal deoxynucleotidyl transferase-mediated dUTP Nick End Labeling; V, ventral.BMC Developmental Biology 2006, 6:62 http://www.biomedcentral.com/1471-213X/6/62
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recruited to regulate development and patterning of dif-
ferent tissues in vertebrates and invertebrates.
In the developing eye, Tbx2, Tbx3 and Tbx5 show 
differential responses to BMP4 signaling
Our data suggest that in the eye, each T-box gene responds
to BMP4 in a different manner. They are consistent with a
model in which Tbx5 responds to BMP4 close to the dor-
sal signaling source, while Tbx2 and Tbx3 can be induced
in a wider area by lower levels of BMP4 secreted from the
source. Based on the expression pattern of Bmp4 in the
dorsal region of the optic vesicle and the optic cup, it is
likely that BMP4 protein concentrations will be high in
the dorsal and low in the ventral region of the eye; indeed
the dorsal retina shows high levels of BMP signaling activ-
ity as determined by immunohistochemistry for Phos-
pho-Smad 1/5/8 proteins.
The different spatial response that each T-box gene
showed and their close evolutionary relationship support
a mechanism of direct regulation by BMP4 signaling,
although we have not excluded the possibility that other
intermediate factors regulate these genes. Significantly, a
recent study showed that the Tbx3 promoter is directly reg-
ulated by BMP Smads, in chromatin immunoprecipita-
tion experiments using extracts from embryonic
hindlimbs, as well as cotransfection assays [69]. In Dro-
sophila, molecular dissection of cis-regulatory sequences of
omb, the homologue of vertebrate Tbx2/3, revealed a Dpp
response element [70] suggesting that omb may also be a
direct target of Dpp signaling. Interestingly, Tbx3
responded more vigorously than Tbx2  to exogenous
BMP4 administered to the lens, extending all the way to
the ventral retina, whereas Tbx2 did not extend as far and
may need other factors or is being inhibited by factors
present in the ventral retina. The fact that Tbx3 expression
is initially more restricted than the Tbx2  expression
domain, yet after exogenous BMP4 treatment it shows the
greatest expansion suggests that other factors are regulat-
ing the expression of T-box genes along with BMP4.
It has been proposed that Tbx5 represses cVax and vice
versa in the chick based on overexpression studies
[21,41]. The cascade in the mouse appears to differ, as
with increased BMP4 levels, we observed repression of
Vax2 without ventral expression of Tbx5. Also, in Vax2
null mice, the Tbx5 expression domain is unchanged [71].
Moreover the separation of Vax2 and Tbx5 expression in
two non-overlapping domains (domains 1 and 4) indi-
cate that these factors are unlikely to control each other's
expression.
Tbx2 subfamily genes as regulators of apoptosis and 
proliferation
Downstream targets regulated by the Tbx2, Tbx3 and Tbx5
transcription factors have not been identified in the eye.
Several in vitro studies implicate these genes in the regula-
tion of cell proliferation and apoptosis. Ectopic expres-
sion of TBX5  in osteosarcoma cells inhibits cell
proliferation and induces apoptosis [72,73]. TBX2 gene
amplification has been detected in primary human breast
cancer tumours, pancreatic cancer cell lines, and its over-
expression detected in melanoma cell lines [74-78]. Both
TBX2  and  TBX3  repress the expression of p14ARF, and
there is evidence for the repression of other cyclin depend-
ent kinase inhibitors p21, p16INK4a, and p15INK4b by TBX2
in vitro [74,79-81]. Moreover, both TBX2 and TBX3 show
anti-senescence properties [74,82], while a dominant neg-
ative form of Tbx2 can induce senescence in a melanoma
cell line [76].
During embryogenesis, a similar pro-proliferative role has
not been identified for these genes. In fact, it has been
shown that the expression of p21, p19ARF, p16INK4a, and
p15INK4b is normal in mice with a targeted mutation of
Tbx2, and there is no evidence for a genetic interaction
between Tbx2 and p53 (Trp53) [83]. Furthermore, Tbx2
expression has been associated with a low rate of prolifer-
ation in the atrioventricular canal during heart develop-
ment [84]. Tbx5  has also been associated with the
regulation of cell proliferation during embryogenesis.
Misexpression of TBX5 in the chick heart leads to inhibi-
tion of cell proliferation [72] and in the limb, ectopic
expression of Tbx5 (or Tbx4) leads to a truncated limb
phenotype due to cell proliferation arrest [68].
We observed a dosage sensitive increase in the amount of
apoptosis in BMP4-treated eyes, which correlates with
Tbx5  expression in the dorsal retina, but not with the
ectopic Tbx2 or Tbx3 expression in the ventral retina. Alter-
natively, the homeobox gene Msx2, which is normally
expressed in the dorsal neural retina [40,65], could be
mediating the apoptotic effect of the elevated BMP4 levels
in the dorsal neural retina. Msx genes mediate BMP
induced apoptosis during development of other organs
such as the hindbrain and the limbs [57,62]. The different
response of Msx2 and the T-box genes to BMP4 treatment
suggests that these genes do not regulate each other. If
Tbx2 acts to reduce proliferation during optic cup forma-
tion, as recently found in the developing heart [84], then
Tbx2 expansion into the ventral retina may contribute to
the observed reduction in levels of proliferation after
BMP4 treatment.
BMP4 dosage in the regulation of eye size and shape
Addition of exogenous BMP4 in the mouse optic cup in
embryo cultures resulted in a reduction in retinal volumeBMC Developmental Biology 2006, 6:62 http://www.biomedcentral.com/1471-213X/6/62
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and alterations in eye shape. In chick and Xenopus, malfor-
mation of the ventral retina has previously been described
after overexpression of BMP4 by electroporation [41,52].
Increases in gene dosage, as well as loss of function are
known to cause congenital eye malformations in humans
and mice, for example in the case of the transcription fac-
tor genes Pax6 and Foxc1 [85,86]. Our findings suggest
that increased levels of BMP4 signaling may be detrimen-
tal; in the human population, such changes could occur,
for instance, via genetic variation in regulatory sequences,
gene duplication, or gain of function mutations. The
recent report that anophthalmia occurs in embryos from
crosses between Bmp4  heterozygous mutants and mice
homozygous for a disrupted allele of Twisted gastrulation
(Tsg), a BMP binding protein that is thought to enhance
BMP4 signaling in the eye [87], also indicates that excess
BMP4 signaling may be as harmful as loss of function.
The adverse consequence of reduced levels of BMP4 sign-
aling for eye development has been explored in different
systems. That optic vesicle development is arrested in
Bmp4  null mice [26] first indicated the importance of
Bmp4 for normal growth. We observed an expansion of
optic stalk and a reduction in the neural retina after addi-
tion of the BMP antagonist, Noggin, close to the dorsal
BMP4 signaling source in the mouse optic cup. In the
chick embryo, misexpression of Noggin induces primarily
ventral abnormalities that include optic stalk hyperplasia
[42]. Conditional gene inactivation has also been used to
analyse the effect of loss of the serine/threonine kinase
membrane bound BMP receptors; BmprIa,  BmprIb, and
BmprII  are expressed in the developing mouse eye
[26,88,89]. Whereas targeted deletion of Bmpr1b  alone
disrupts the ability of many ventrally located ganglion
cells to enter the optic nerve head [88], conditional
Bmpr1a-/fx/Bmpr1b-/-;cre  double mutant embryos exhibit
more profound structural abnormalities due to excess
apoptosis and reduced proliferation at E11.5, and show
anophthalmia at birth [61]. In these mutants, the loss of
Bmpr1a and Bmpr1b likely interfered with BMP4 signal-
ing, as well as signaling by BMP7, BMP2 and BMP3, from
non-neural retinal sources [90].
The findings of altered eye size and shape with loss and
gain of BMP4 function, suggest that a BMP4 signaling gra-
dient mediates control of proliferation across the D-V axis
during optic cup morphogenesis. With exogenous BMP4,
we observed a significantly decreased level of retinal cell
proliferation in both the dorsal and the ventral retina.
Regional differences in proliferation have recently been
found during optic cup growth [4,5], and we found that
the exogenous BMP4 acted to equalise the differences in
levels of proliferation across the D-V axis. Other studies
have linked excess BMP4 to reduced proliferation and
increased apoptosis. For example, the BMP expressing
region of the mouse telencephalon has a lower prolifera-
tive activity and higher level of apoptosis than the rest of
the forebrain, and BMP4-soaked beads can induce apop-
tosis in telencephalic explants [66]. In the chick, exoge-
nous BMP4 applied to the dorsal optic cup, or at early
stages to the telencephalon also increases apoptosis
[40,91]. However, in the same studies, addition of BMP4
to chick retinal cultures at later stages induced prolifera-
tion [40], while reduced levels of BMP signaling (via Nog-
gin misexpression) in the telencephalon was associated
only with a decrease in proliferating cells [91], highlight-
ing that the cellular response to BMP4 signaling appears
stage and context dependent. In our study, only at higher
doses of BMP4 was widespread apoptosis induced.
Threshold-specific requirements for BMP4 in optic cup 
development
Our data show that a major role for dorsal BMP4 signaling
in the developing mouse optic cup is to regulate gene
expression across the D-V axis. It suggests that BMP4 may
be critically important for providing a signaling gradient,
which is used to demarcate gene expression domains
across the D-V axis, with retinal cells expressing different
transcription factor genes in response to different thresh-
old levels of BMP4 activity. Variations in Smad binding
site distribution between target genes or levels of other
active cofactors are likely to contribute to the differential
gene responses.
Exogenous BMP4 treatment prior to optic cup formation
affected Tbx2 and Tbx5, but not Vax2 or Tbx3, and T-box
gene expression changes were not induced in the ventral
retina in contrast to the effect of exogenous BMP4 addi-
tion to the lens. These differences may be due to the dif-
ferent developmental stage, and/or the different range of
BMP signaling from bead implantation in the lens com-
pared with the extraocular mesenchyme. In the latter case
the different intervening tissue between the bead and the
retina that is exposed to the BMP signal may be signifi-
cant; when a bead is implanted in the lens the intervening
tissue is the lens, whereas from a bead located in the mes-
enchyme, the BMP signal has to pass through the pre-
sumptive RPE. We were only able to detect increased
levels of Phospho-Smad 1/5/8 immuno-labeling after
BMP4 bead implantation in the lens, which correlates
with our findings that lens bead implantation showed the
most dramatic effect on gene expression domains. In this
study it was not possible to distinguish if the BMP gradi-
ent regulates the expression of the Tbx2 subfamily genes
directly or indirectly. Rather than the BMP gradient being
directly responsible for the nested expression domains it
is possible that there are other secondary molecules
induced by BMP that carry the signal. However, our data
considered together with recent data showing that the
Tbx3 promoter is directly regulated by Smads [69] stronglyBMC Developmental Biology 2006, 6:62 http://www.biomedcentral.com/1471-213X/6/62
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support the idea that these genes respond directly to a
BMP4 signaling gradient.
Although there are some differences in the specific gene
expression patterns between chick and mouse, the
broadly conserved pattern of gene expression domains
across the D-V axis of the optic cup suggests that compart-
ment-like units of clonally related cells defined by
restricted gene expression domains, as previously
described in the chick [6], may also exist in the mouse. If
this is the case, then our data suggests that altering the
BMP4 concentration in the eye re-specifies the compart-
ments of the retina along the D-V axis; increased BMP
causes compartments to express markers normally
expressed by their more dorsal neighbours, although the
response to BMP4 is not uniform in the different genes
examined. Our analysis of proliferation and apoptosis
support the conclusion that these changes in gene expres-
sion domains reflect changes in the identity of retinal ter-
ritories rather than tissue loss. Instead of being made up
of domains 1, 2, 3 and 4, the post BMP-treatment eye con-
sists only of domains 1, 2 and a modified domain 3
(domain 3* that lacks Tbx2  and  Vax2  expression but
expresses Tbx3). The importance of correct spatial restric-
tion of gene expression for topographic mapping of reti-
nal ganglion cells to the brain is well established
[21,41,92]; our data suggests it is also important in regu-
lating regional growth of the developing optic cup.
Our finding that exogenous BMP4 not only extends
expression of the dorsally expressed T-box genes in the
optic cup, but also reduces the ventral marker Vax2 sup-
port the idea that BMP4 signaling has a long-range action
across the D-V axis, and that BMP4 may repress Vax2
expression. BMP inhibitors, in particular Ventroptin and
Dan, are known to be expressed in a ventral-high gradient
in the chick eye [93,94], although these expression pat-
terns have not been reported in the mouse. The role of
such inhibitors may normally be to block long range
BMP4 signaling from acting in the ventral-most region
(domain 4), allowing Vax2  expression, and preventing
induction of dorsally expressed genes. In our study,
increased levels of BMP4 at optic cup stage are apparently
sufficient to overcome endogenous inhibitors, leading to
Vax2 repression and induction of T-box gene expression
in the ventral retina.
Also consistent with the proposal that BMP regulates
Vax2, the recent informative study by Murali et al [61],
showed that with reduced levels of BMP signaling, Tbx5
expression was lost whereas Vax2  expression was
expanded into the dorsal mouse retina in Bmpr1a-/fx/
Bmpr1b+/-;Cre double mutants. In chick, retroviral overex-
pression of Bmp4 was previously shown to repress expres-
sion of Ventroptin [94]. Alternative to direct regulation of
Vax2 by BMP4, interaction with other ventral signaling
pathways could be important, as in zebrafish and chick,
hedgehog signaling from the ventral midline contributes
to regulation of the Vax gene [95,96]. Mouse embryos
cannot be cultured ex utero for long enough to analyse the
effect of the shifted gene expression domains on late
stages of eye development. Nevertheless, the effect of loss
of Vax2 expression in the ventral eye has already been
carefully studied in Vax2 null mice and shown to cause
profound defects in ventral eye formation and coloboma
[20,22,97].
Conclusion
Our data suggest that BMP4 signaling from a dorsal site of
expression, patterns the mammalian optic cup across the
entire D-V axis, by dosage dependent regulation of target
genes, Tbx2, Tbx3, Tbx5 and Vax2. Our findings fit with the
idea that a BMP4 signaling gradient across the developing
optic cup is interpreted to create domains of BMP4 target
gene expression. A conserved genetic pathway is emerging
whereby BMP4 regulates members of the Tbx2 subfamily
in different tissues and organisms during organogenesis.
Increasing evidence suggests that Tbx2 and Tbx3 may reg-
ulate proliferation in cancer and in development and our
data is consistent with a role for these T-box genes down-
stream of BMP4 in regulating proliferation of the optic
cup. Upon increasing the level of BMP4 signaling, growth
of the embryonic eye was perturbed resulting in a reduc-
tion in retinal volume as well as the D-V and N-T axial
lengths of the optic cup. That precise levels of BMP4 sign-
aling are critical for normal mammalian eye development
is becoming progressively more clear; it is likely that
altered dosage of BMP4 is a mechanism underlying
human congenital eye defects.
Methods
Whole mouse embryo culture
Mouse embryos at E9.5, E10.5, and E11.5 were obtained
from timed matings of CBA/Ca mice. Days on which
plugs were found after overnight matings were considered
to be E0.5. Embryos were dissected and cultured based on
the method of D.L Cockroft [58,98]. E9.5 embryos were
cultured with intact yolk sacs, whereas E10.5 and E11.5
embryos were cultured outside the yolk sac. For E10.5 and
E11.5 embryos, a small incision was made in the yolk sac
adjacent to the placenta, avoiding large blood vessels. The
yolk sac and the amnion were then drawn over the head
of the embryo. Embryos were incubated at 37°C in a roll-
ing incubator (B.T.C. Engineering, Cambridge, UK) in 3
ml culture medium consisting of 100% rat serum (pre-
pared as described in [98]) for E9.5 embryos or 25% rat
serum 75% culture saline (0.12 M NaCl, 4 M KCl, 0.4 mM
MgSO4, 0.25 mM MgCl2, 0.60 mM NaH2PO4, 1.8 mM
CaCl2, 11.1 mM glucose, 24 mM NaHCO3) for E10.5–
11.5 embryos. The medium was manually gassed prior toBMC Developmental Biology 2006, 6:62 http://www.biomedcentral.com/1471-213X/6/62
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culture for one minute with a 20% O2/5% CO2 source for
E9.5, and 95% O2/5% CO2 (Crysoservice Ltd, UK) for
E10.5–E11.5. Embryos were cultured for 1 hour before
bead implantation.
Bead implantation
10 μl of Affi-Gel Blue beads, diameter 80–150 μm (Bio-
Rad Laboratories, CA, USA), were washed three times in
embryo water (Sigma, UK), then incubated in 5 μl of
either 100 μgml-1 human recombinant BMP4 (R&D Sys-
tems, UK), or 1 mgml-1 Noggin (R&D Systems, UK), or 1
mgml-1 bovine serum albumen (BSA; Promega, USA), for
1 hour at 37°C prior to implantation. High concentration
BMP4 beads were prepared as previously described [99].
E9.5 mouse embryos with intact yolk sacs were transferred
to a dish of explanting saline (same as culture saline
except 0.83 mM glucose, 0.6 mM NaHCO3). To enable
bead implantation, a small tear was made using watch-
maker's forceps (Raymond Lamb, UK) in the yolk sac
adjacent to the ectoplacental cone, then an arc was cut
using iridectomy scissors around one third of the cone
(adjacent to the embryonic head). Watchmaker's forceps
were used to tear the amniotic sac and expose the eye
region. E10.5 and E11.5 embryos with their yolk sac
removed, were rested on their side in explanting saline to
expose the eye. The site of bead implantation was pierced
using a tungsten needle and then using a mouth-operated
glass capillary pipette, a bead was inserted into the extra-
ocular mesenchyme (at E9.5 and E10.5) or in the lens ves-
icle (at E11.5). Following bead implantation, embryos
were gassed again for 1 minute and cultured for 18 hours
at 37°C. Embryos were scored after culture for blood cir-
culation, number of somites and head length [98].
Embryos were only analysed when circulation was main-
tained and somite number had increased by at least 6
pairs during culture. Overnight ex utero growth of optic
vesicle stage embryos (somite stage 24–26) to somite
stages 33–35 resulted in optic vesicle invagination. Over-
night ex utero growth of optic cup stage embryos (somite
stage 33–35) to somite stages ≥ 44 resulted in normal
growth and pigmentation of the optic cup. For each treat-
ment, viable post culture embryos from at least two litters
were analysed in independent experiments. After culture,
embryos were fixed overnight in 4% para-formaldehyde
(PFA) for analysis.
Wholemount in situ hybridisation
RNA in situ hybridisation was performed on 4% PFA fixed
cultured, operated and control embryos using standard
protocols [100]. For detection of single genes, digoxigenin
(DIG)-labelled RNA probes were prepared for Tbx2, Tbx3,
Tbx5,  Msx2, and Vax2  using a DIG RNA labeling kit
(Roche, Germany) according to the manufacturer's
description. For detection of Tbx2 and Vax2 by double in
situ hybridisation, Tbx2 DIG-labelled and Vax2 fluores-
cein-labelled probes were prepared and hybridised simul-
taneously. Plasmids used were a 2.2 kb Tbx2 cDNA in
pBK-CMV, 3 kb Tbx5 cDNA in pBK-CMV [50], 1 kb Tbx3
cDNA in pB(II)KS (kindly provided by V. Papaioannou,
Columbia University), a 700 bp Vax2 cDNA in pBS SK
(kindly provided by C. Cepko, Harvard Medical School),
and a 1000 bp Msx2 cDNA in pCR2.1 (kindly provided by
P. Sharpe, King's College London). Hybridisation of
labelled probe was visualised using alkaline phosphatase
conjugated anti-DIG antibody and the colour reaction
was developed with NBT/BCIP (Roche, Germany); treated
and control eyes of the same embryo were compared
ensuring identical reaction conditions. For double in situ
hybridisation, the Vax2 probe was detected with alkaline
phosphatase conjugated anti-fluorescein antibody and
the colour reaction developed with NBT/BCIP. Embryos
were then incubated at 65°C for 30 minutes in TBST (137
mM NaCl, 2.7 mM KCl, 0.25 M Tris.HCl pH 7.5, 1%
Tween-20, 2 mM Levamisol), blocked in TBST containing
10% heat-inactivated sheep serum for 1 hour at room
temperature and incubated with anti-DIG antibody for
detection of the Tbx2 probe with INT/BCIP (Roche, Ger-
many).
Microscopy
Images of whole mount embryos were captured with a
Leica MZ FLIII microscope fitted with a Leica DC500 cam-
era using the Leica IM1000 Image manager V1.20 software
(Leica, Germany), and imported into Adobe Photoshop
(6.0). Vibratome sections (50 μm) prepared after whole
mount in situ hybridisation were imaged using an Axio-
phot 2 (Zeiss, Germany) with differential interference
contrast (DIC) optics, a Leica digital MZIII camera and
Openlab 4.0.4 software (Improvision Ltd., UK). Fluores-
cent images of sections after immunohistochemistry were
digitally captured using an Axiophot (Zeiss, Germany)
microscope, ProgRes Cl4 camera (Jenoptik Jena, Ger-
many) and Openlab 4.0.4 software.
Morphometric analysis
To estimate retinal volume, post-culture embryos were
embedded in 0.45% w/v gelatine, 28% w/v egg albumin,
18 % w/v sucrose, 0.2% glutaraldehyde (all from Sigma,
UK) in phosphate buffered saline (PBS). Serial transverse
vibratome sections (50 μm) of each eye were mounted on
slides with 50% glycerol/PBS and glass coverslips. Retinal
surface area per section was estimated using Openlab
4.0.4 software. Retinal volume per section was calculated
as retinal surface area multiplied by section thickness, and
total retinal volume was calculated by addition of retinal
volumes of all sections per eye. BMP4-treated eyes were
compared to contralateral BSA-treated eyes using the
paired t-test. To determine the proximo-distal (P-Di) axis,
the distance from the ventricular edge of the retina to the
surface ectoderm was measured using Openlab 4.0.4 soft-BMC Developmental Biology 2006, 6:62 http://www.biomedcentral.com/1471-213X/6/62
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ware on serial sections and the longest distance for each
optic cup was compared with the paired t-test. To deter-
mine the dorso-ventral (D-V) and naso-temporal (N-T)
axial lengths of optic cups after culture, digital images of
optic cups captured using identical conditions, were
measured using the Photoshop (6.0) measure tool. Oper-
ated eyes were compared to contralateral eyes in each
embryo using the paired t-test.
Immunohistochemistry, analysis of cell proliferation, 
apoptosis, and histology
Phospho-Smad 1/5/8 immunohistochemistry was per-
formed on coronal wax sections of 4% PFA fixed post-cul-
ture embryos. Sections (7 μm) were de-parafinised and
un-masked by steaming in Declear (Cellmarque, USA) for
40 minutes and then incubated in 3% H2O2 in TBS (137
mM NaCl, 2.7 mM KCl, 0.25 M Tris pH7.5) containing
0.1% Triton-X100 (BDH, UK) for 10 minutes. Sections
were incubated in blocking solution (5% v/v goat serum,
0.15% w/v glycine, 2 mg/ml BSA in TBS-0.1% Triton-
X100) for 30 minutes and then in blocking solution con-
taining a 1:100 dilution of the Phospho-Smad1/5/8 anti-
body (Cell Signaling technology, USA) for 1 hour at room
temperature. This was followed by incubation in a 1:250
dilution of Biotinylated goat anti-rabbit (Dako, Den-
mark) secondary antibody in blocking solution for 1 hour
at room temperature. The secondary antibody was
detected with the Vectastain ABC kit (Vector Laboratories,
USA) and the diaminobenzidine tetrahydrochloride
(DAB; Sigma, UK) chromogen according to the manufac-
turers' descriptions. Sections were counterstained with
0.5% w/v methyl green (BDH, UK). Histology was exam-
ined on 7 μm thick coronal wax sections stained with Hae-
matoxylin and Eosin (BDH, UK). Frozen coronal sections
of 4% PFA fixed, OCT (BDH, UK) embedded, post-culture
embryos were prepared for analysis of cell proliferation
and apoptosis. Anti-phospho-histone H3 (pH3) immu-
nohistochemistry was used to detect mitotic cells in the
neural retina. Sections were incubated in blocking solu-
tion (10% foetal calf serum, 1% bovine serum albumin,
0.1% Tween-20 in PBS) for 1 hour, followed by incuba-
tion with primary antibody, rabbit anti-pH3 (1:100 dilu-
tion in blocking solution, Upstate, USA), overnight at
4°C. Sections were incubated with FITC-conjugated goat
anti-rabbit secondary antibody (1:100 in blocking solu-
tion, Jackson Immunoresearch laboratories, USA) and
propidium iodide (1 μgml-1, Sigma, UK), for 1 hour at
room temperature. pH3-positive cells were counted in 3–
5 midline sections per eye per embryo (n = 4 embryos). A
2-way Analysis of Variance (ANOVA) was used to test
whether the number of pH3 cells per section differed
between paired BMP4-treated and contralateral non-
treated eyes. The Shapiro-Wilk's test of normality was
used to confirm that residual values (observed value –
value predicted by the model) were normally distributed.
Total cell number per section was counted on digital
images in Photoshop (6.0). The effect of total cell number
on the number of pH3-positive cells was tested by incor-
porating total cell number per section as a covariate in the
Analysis of Co-Variance (ANCOVA) test. To investigate
whether the reduction in the number of mitotic cells is
regional along the D-V axis of the neural retina, retinal
sections were divided into a dorsal region above the optic
stalk (including domains 1, 2 and 3) and a ventral region
below the optic stalk (containing the Vax2  expression
domain 4) and pH3 labelled cells were counted in each
region.
TUNEL (Terminal deoxynucleotidyl transferase-mediated
dUTP Nick End Labeling, Roche, UK) was used to detect
apoptotic cells according to the manufacturer's descrip-
tion. Briefly, frozen sections were permeabilised with
0.1% Triton X-100 in PBS for 2 minutes and incubated at
37 C° for 1 hour with TUNEL mix. Afterwards, sections
were counterstained with propidium iodide (1 μgml-1,
Sigma, UK) in PBS and mounted with CITIFLUOR. The
number of TUNEL-positive cells was counted in dorsal,
central, and ventral retinal regions in 2–3 midline sections
of eyes in five embryos and compared between the BMP4-
treated and non-treated contralateral eyes using a 2-way
ANOVA; retinal area was incorporated into an ANCOVA
to test for the effect of retinal size on the number of
TUNEL positive nuclei (TUNEL index).
Authors' contributions
HB and JKLH carried out the bead implantation and
whole embryo culture experiments. HB carried out the
proliferation and apoptosis study, the morphometric and
statistical analyses, prepared the figures, and assisted with
the preparation of the manuscript. JCS conceived of the
study and wrote the manuscript. All authors read and
approved the final manuscript.BMC Developmental Biology 2006, 6:62 http://www.biomedcentral.com/1471-213X/6/62
Page 20 of 22
(page number not for citation purposes)
Additional material
Acknowledgements
We are very grateful to Professor Andrew Copp for help in establishing the 
mouse embryo culture system and to Dr Deborah Henderson and Dr 
Patrizia Ferretti for critical comments and discussions. We would like to 
thank Professor Tim Cole for guidance with the statistical analysis and Ms 
Katy Gardner for provision of material. The study was supported by grants 
from the Child Health Research Appeal Trust and the Medical Research 
Council UK (G120/191). Research at the Institute of Child Health and 
Great Ormond Street Hospital for Children NHS Trust benefits from 
Research and Development funding received from the NHS Executive.
References
1. Chow RL, Lang RA: Early eye development in vertebrates.  Annu
Rev Cell Dev Biol 2001, 17:255-296.
2. Larsen WJ: Human embryology.  2001.
3. Graw J: The genetic and molecular basis of congenital eye
defects.  Nat Rev Genet 2003, 4:876-888.
4. Calvente R, Carmona R, Abadia-Molina F, Abadia-Fenoll F: Stereo-
logical study on the mode of optic cup expansion and the
accumulation of mitoses in the early stages of chick embryo
development.  Anat Rec 1988, 222:401-407.
5. Morcillo J, Martínez-Morales JR, Trousse F, Fermin Y, Sowden JC,
Bovolenta P: Proper patterning of the optic fissure requires
the sequential activity of BMP7 and SHH.  Development 2006,
133:3179-3190.
6. Peters MA, Cepko CL: The dorsal-ventral axis of the neural ret-
ina is divided into multiple domains of restricted gene
expression which exhibit features of lineage compartments.
Dev Biol 2002, 251:59-73.
7. Reilly KM, Melton DA: Short-range signaling by candidate mor-
phogens of the TGF beta family and evidence for a relay
mechanism of induction.  Cell 1996, 86:743-754.
8. Sanson B: Generating patterns from fields of cells. Examples
from Drosophila segmentation.  EMBO Rep 2001, 2:1083-1088.
9. Kerszberg M: Morphogen propagation and action: towards
molecular models.  Semin Cell Dev Biol 1999, 10:297-302.
10. Wolpert L, Kerszberg M: Patterning and positional information.
In Patterning in vertebrate development Edited by: Tickle C. Oxford,
Oxford University Press; 2003:1-9. 
11. Peters MA: Patterning the neural retina.  Curr Opin Neurobiol
2002, 12:43-48.
12. Lupo G, Harris WA, Lewis KE: Mechanisms of ventral patterning
in the vertebrate nervous system.  Nat Rev Neurosci 2006,
7:103-114.
13. Molotkov A, Molotkova N, Duester G: Retinoic acid guides eye
morphogenetic movements via paracrine signaling but is
unnecessary for retinal dorsoventral patterning.  Development
2006, 133:1901-1910.
14. Matt N, Dupe V, Garnier JM, Dennefeld C, Chambon P, Mark M, Ghy-
selinck NB: Retinoic acid-dependent eye morphogenesis is
orchestrated by neural crest cells.  Development 2005,
132:4789-4800.
15. Hyatt GA, Schmitt EA, Marsh-Armstrong N, McCaffery P, Drager UC,
Dowling JE: Retinoic acid establishes ventral retinal character-
istics.  Development 1996, 122:195-204.
16. Marsh-Armstrong N, McCaffery P, Gilbert W, Dowling JE, Drager
UC: Retinoic acid is necessary for development of the ventral
retina in zebrafish.  Proc Natl Acad Sci U S A 1994, 91:7286-7290.
17. Macdonald R, Barth KA, Xu Q, Holder N, Mikkola I, Wilson SW:
Midline signalling is required for Pax gene regulation and
patterning of the eyes.  Development 1995, 121:3267-3278.
18. Schimmenti LA, de la Cruz J, Lewis RA, Karkera JD, Manligas GS,
Roessler E, Muenke M: Novel mutation in sonic hedgehog in
non-syndromic colobomatous microphthalmia.  Am J Med
Genet 2003, 116A:215-221.
19. Roessler E, Belloni E, Gaudenz K, Vargas F, Scherer SW, Tsui LC,
Muenke M: Mutations in the C-terminal domain of Sonic
Hedgehog cause holoprosencephaly.  Hum Mol Genet 1997,
6:1847-1853.
20. Mui SH, Kim JW, Lemke G, Bertuzzi S: Vax genes ventralize the
embryonic eye.  Genes Dev 2005, 19:1249-1259.
21. Schulte D, Furukawa T, Peters MA, Kozak CA, Cepko CL: Misex-
pression of the Emx-related homeobox genes cVax and
mVax2 ventralizes the retina and perturbs the retinotectal
map.  Neuron 1999, 24:541-553.
22. Barbieri AM, Broccoli V, Bovolenta P, Alfano G, Marchitiello A, Moc-
chetti C, Crippa L, Bulfone A, Marigo V, Ballabio A, Banfi S: Vax2
inactivation in mouse determines alteration of the eye dor-
sal-ventral axis, misrouting of the optic fibres and eye colo-
boma.  Development 2002, 129:805-813.
23. Torres M, Gomez-Pardo E, Gruss P: Pax2 contributes to inner
ear patterning and optic nerve trajectory.  Development 1996,
122:3381-3391.
24. Hemmati-Brivanlou A, Thomsen GH: Ventral mesodermal pat-
terning in Xenopus embryos: expression patterns and activ-
ities of BMP-2 and BMP-4.  Dev Genet 1995, 17:78-89.
25. Francis PH, Richardson MK, Brickell PM, Tickle C: Bone morpho-
genetic proteins and a signalling pathway that controls pat-
terning in the developing chick limb.  Development 1994,
120:209-218.
26. Furuta Y, Hogan BL: BMP4 is essential for lens induction in the
mouse embryo.  Genes Dev 1998, 12:3764-3775.
Additional File 1
Tbx3, Vax2, Msx2 expression and Phospho-Smad 1/5/8 localisation 
after alteration of BMP4 signaling in embryo culture by addition of 
exogenous Noggin or BMP4. (A, B) Post-culture embryo showing nor-
mal dorsal Tbx3 expression in the control non-treated and Noggin-treated 
optic cups respectively. (C, D) Post-culture embryo showing normal ven-
tral Vax2 expression in the control non-treated and Noggin-treated optic 
cups respectively. (E) The boundary of Bmp4 expression (arrow) in the 
dorsal neural retina of an E11.5 embryo. (F) Post-culture embryo showing 
high levels of Phospho-Smad 1/5/8 labeling in the dorsal neural retina 
and in the lens. The extent of the highest level of BMP signaling in the 
retina is demarcated by arrow. (G) BMP4-treated contralateral eye show-
ing a wider region of high level Phospho-Smad 1/5/8 labeling (arrow). 
(H, I) Another example of the extension of BMP signaling in the BMP4-
treated optic cup (I) as compared with the control eye (H) in a post-cul-
ture embryo. Sections H and I are counterstained with methyl green. (J) 
Post-culture embryo showing normal Msx2 expression restricted to the 
dorsal neural retina and lens. (K) BMP4-treated contralateral eye show-
ing widespread induction of Msx2 expression in the lens and the optic cup. 
Noggin or BMP4-soaked beads are indicated with asterisks (in A-K) and 
domains of gene expression are demarcated with arrows (in A-D). E-I 
show coronal sections of eyes. Abbreviations: L, lens vesicle; NR, neural 
retina.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-6-62-S1.pdf]
Additional File 2
Analysis of pH3 and TUNEL in the dorsal and ventral retina after 
BMP4 treatment. (A, B) Graphs show the number of mitotic cells per sec-
tion per eye in the dorsal (A) and ventral (B) regions of BMP4-treated 
optic cups compared with contralateral control optic cups (n = 44 sections 
from 4 embryos; p = 0.007 in dorsal, p = 0.018 in ventral by ANOVA). 
(C) Graph shows the programmed cell death index (per section per eye) 
in the dorsal neural retina of BMP4-treated and contralateral control eyes 
(n = 26 sections in 5 embryos; p = 0.044 by ANCOVA). Data was Ln 
transformed for normalisation.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-6-62-S2.pdf]BMC Developmental Biology 2006, 6:62 http://www.biomedcentral.com/1471-213X/6/62
Page 21 of 22
(page number not for citation purposes)
27. Eldar A, Dorfman R, Weiss D, Ashe H, Shilo BZ, Barkai N: Robust-
ness of the BMP morphogen gradient in Drosophila embry-
onic patterning.  Nature 2002, 419:304-308.
28. Dosch R, Gawantka V, Delius H, Blumenstock C, Niehrs C: Bmp-4
acts as a morphogen in dorsoventral mesoderm patterning
in Xenopus.  Development 1997, 124:2325-2334.
29. Jones CM, Smith JC: Establishment of a BMP-4 morphogen gra-
dient by long-range inhibition.  Dev Biol 1998, 194:12-17.
30. Raftery LA, Sutherland DJ: Gradients and thresholds: BMP
response gradients unveiled in Drosophila embryos.  Trends
Genet 2003, 19:701-708.
31. Nellen D, Burke R, Struhl G, Basler K: Direct and long-range
action of a DPP morphogen gradient.  Cell 1996, 85:357-368.
32. Lecuit T, Brook WJ, Ng M, Calleja M, Sun H, Cohen SM: Two dis-
tinct mechanisms for long-range patterning by Decapenta-
plegic in the Drosophila wing.  Nature 1996, 381:387-393.
33. Zhao Z, Rivkees SA: Programmed cell death in the developing
heart: regulation by BMP4 and FGF2.  Dev Dyn 2000,
217:388-400.
34. Duprez D, Bell EJ, Richardson MK, Archer CW, Wolpert L, Brickell
PM, Francis-West PH: Overexpression of BMP-2 and BMP-4
alters the size and shape of developing skeletal elements in
the chick limb.  Mech Dev 1996, 57:145-157.
35. Liu W, Selever J, Murali D, Sun X, Brugger SM, Ma L, Schwartz RJ,
Maxson R, Furuta Y, Martin JF: Threshold-specific requirements
for Bmp4 in mandibular development.  Dev Biol 2005,
283:282-293.
36. Sinervo B: Darwin's finch beaks, Bmp4, and the developmen-
tal origins of novelty.  Heredity 2005, 94:141-142.
37. Wu P, Jiang TX, Suksaweang S, Widelitz RB, Chuong CM: Molecular
shaping of the beak.  Science 2004, 305:1465-1466.
38. Abzhanov A, Protas M, Grant BR, Grant PR, Tabin CJ: Bmp4 and
morphological variation of beaks in Darwin's finches.  Science
2004, 305:1462-1465.
39. Mehler MF, Mabie PC, Zhang D, Kessler JA: Bone morphogenetic
proteins in the nervous system.  Trends Neurosci 1997,
20:309-317.
40. Trousse F, Esteve P, Bovolenta P: Bmp4 mediates apoptotic cell
death in the developing chick eye.  J Neurosci 2001,
21:1292-1301.
41. Koshiba-Takeuchi K, Takeuchi JK, Matsumoto K, Momose T, Uno K,
Hoepker V, Ogura K, Takahashi N, Nakamura H, Yasuda K, Ogura T:
Tbx5 and the retinotectum projection.  Science 2000,
287:134-137.
42. Adler R, Belecky-Adams TL: The role of bone morphogenetic
proteins in the differentiation of the ventral optic cup.  Devel-
opment 2002, 129:3161-3171.
43. Chang B, Smith RS, Peters M, Savinova OV, Hawes NL, Zabaleta A,
Nusinowitz S, Martin JE, Davisson ML, Cepko CL, Hogan BL, John
SW: Haploinsufficient Bmp4 ocular phenotypes include ante-
rior segment dysgenesis with elevated intraocular pressure.
BMC Genet 2001, 2:18.
44. Dunn NR, Winnier GE, Hargett LK, Schrick JJ, Fogo AB, Hogan BL:
Haploinsufficient phenotypes in Bmp4 heterozygous null
mice and modification by mutations in Gli3 and Alx4.  Dev Biol
1997, 188:235-247.
45. Lemyre E, Lemieux N, Decarie JC, Lambert M:
Del(14)(q22.1q23.2) in a patient with anophthalmia and pitu-
itary hypoplasia.  Am J Med Genet 1998, 77:162-165.
46. Ahmad ME, Dada R, Dada T, Kucheria K: 14q(22) deletion in a
familial case of anophthalmia with polydactyly.  Am J Med Genet
A 2003, 120:117-122.
47. Bennett CP, Betts DR, Seller MJ: Deletion 14q (q22q23) associ-
ated with anophthalmia, absent pituitary, and other abnor-
malities.  J Med Genet 1991, 28:280-281.
48. Nolen LD, Amor D, Haywood A, St Heaps L, Willcock C, Mihelec M,
Tam P, Billson F, Grigg J, Peters G, Jamieson RV: Deletion at 14q22-
23 indicates a contiguous gene syndrome comprising anoph-
thalmia, pituitary hypoplasia, and ear anomalies.  Am J Med
Genet A 2006.
49. Grimm S, Pflugfelder GO: Control of the gene optomotor-blind
in Drosophila wing development by decapentaplegic and
wingless.  Science 1996, 271:1601-1604.
50. Sowden JC, Holt JK, Meins M, Smith HK, Bhattacharya SS: Expres-
sion of Drosophila omb-related T-box genes in the develop-
ing human and mouse neural retina.  Invest Ophthalmol Vis Sci
2001, 42:3095-3102.
51. Agulnik SI, Garvey N, Hancock S, Ruvinsky I, Chapman DL, Agulnik I,
Bollag R, Papaioannou V, Silver LM: Evolution of mouse T-box
genes by tandem duplication and cluster dispersion.  Genetics
1996, 144:249-254.
52. Sasagawa S, Takabatake T, Takabatake Y, Muramatsu T, Takeshima K:
Axes establishment during eye morphogenesis in Xenopus
by coordinate and antagonistic actions of BMP4, Shh, and
RA.  Genesis 2002, 33:86-96.
53. Yamada M, Revelli JP, Eichele G, Barron M, Schwartz RJ: Expression
of chick Tbx-2, Tbx-3, and Tbx-5 genes during early heart
development: evidence for BMP2 induction of Tbx2.  Dev Biol
2000, 228:95-105.
54. Tumpel S, Sanz-Ezquerro JJ, Isaac A, Eblaghie MC, Dobson J, Tickle C:
Regulation of Tbx3 expression by anteroposterior signalling
in vertebrate limb development.  Dev Biol 2002, 250:251-262.
55. Gross JM, Dowling JE: Tbx2b is essential for neuronal differen-
tiation along the dorsal/ventral axis of the zebrafish retina.
Proc Natl Acad Sci U S A 2005, 102:4371-4376.
56. Eichele G, Tickle C, Alberts BM: Microcontrolled release of bio-
logically active compounds in chick embryos: beads of 200-
microns diameter for the local release of retinoids.  Anal Bio-
chem 1984, 142:542-555.
57. Ganan Y, Macias D, Duterque-Coquillaud M, Ros MA, Hurle JM: Role
of TGF beta s and BMPs as signals controlling the position of
the digits and the areas of interdigital cell death in the devel-
oping chick limb autopod.  Development 1996, 122:2349-2357.
58. Copp A, Cogram P, Fleming A, Gerrelli D, Henderson D, Hynes A,
Kolatsi-Joannou M, Murdoch J, Ybot-Gonzalez P: Neurulation and
neural tube closure defects.  In Developmental Biology Protocols Vol-
ume 136. Edited by: Tuan RS and Lo CW. Totowa, NJ, Humana Press
Inc.; 2000:135-160. 
59. Zimmerman LB, De Jesus-Escobar JM, Harland RM: The Spemann
organizer signal noggin binds and inactivates bone morpho-
genetic protein 4.  Cell 1996, 86:599-606.
60. Shi Y, Massague J: Mechanisms of TGF-beta signaling from cell
membrane to the nucleus.  Cell 2003, 113:685-700.
61. Murali D, Yoshikawa S, Corrigan RR, Plas DJ, Crair MC, Oliver G,
Lyons KM, Mishina Y, Furuta Y: Distinct developmental pro-
grams require different levels of Bmp signaling during mouse
retinal development.  Development 2005, 132:913-923.
62. Graham A, Francis-West P, Brickell P, Lumsden A: The signalling
molecule BMP4 mediates apoptosis in the rhombencephalic
neural crest.  Nature 1994, 372:684-686.
63. Hollnagel A, Oehlmann V, Heymer J, Ruther U, Nordheim A: Id
genes are direct targets of bone morphogenetic protein
induction in embryonic stem cells.  J Biol Chem 1999,
274:19838-19845.
64. Barlow AJ, Francis-West PH: Ectopic application of recombinant
BMP-2 and BMP-4 can change patterning of developing chick
facial primordia.  Development 1997, 124:391-398.
65. Monaghan AP, Davidson DR, Sime C, Graham E, Baldock R, Bhattach-
arya SS, Hill RE: The Msh-like homeobox genes define domains
in the developing vertebrate eye.  Development 1991,
112:1053-1061.
66. Furuta Y, Piston DW, Hogan BL: Bone morphogenetic proteins
(BMPs) as regulators of dorsal forebrain development.  Devel-
opment 1997, 124:2203-2212.
67. Zou H, Niswander L: Requirement for BMP signaling in inter-
digital apoptosis and scale formation.  Science 1996,
272:738-741.
68. Rodriguez-Esteban C, Tsukui T, Yonei S, Magallon J, Tamura K, Izpisua
Belmonte JC: The T-box genes Tbx4 and Tbx5 regulate limb
outgrowth and identity.  Nature 1999, 398:814-818.
69. Yang L, Cai CL, Lin L, Qyang Y, Chung C, Monteiro RM, Mummery
CL, Fishman GI, Cogen A, Evans S: Isl1Cre reveals a common
Bmp pathway in heart and limb development.  Development
2006, 133:1575-1585.
70. Sivasankaran R, Vigano MA, Muller B, Affolter M, Basler K: Direct
transcriptional control of the Dpp target omb by the DNA
binding protein Brinker.  Embo J 2000, 19:6162-6172.
71. Barbieri AM, Lupo G, Bulfone A, Andreazzoli M, Mariani M, Fouger-
ousse F, Consalez GG, Borsani G, Beckmann JS, Barsacchi G, Ballabio
A, Banfi S: A homeobox gene, vax2, controls the patterning ofPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Developmental Biology 2006, 6:62 http://www.biomedcentral.com/1471-213X/6/62
Page 22 of 22
(page number not for citation purposes)
the eye dorsoventral axis.  Proc Natl Acad Sci U S A 1999,
96:10729-10734.
72. Hatcher CJ, Kim MS, Mah CS, Goldstein MM, Wong B, Mikawa T, Bas-
son CT: TBX5 transcription factor regulates cell proliferation
during cardiogenesis.  Dev Biol 2001, 230:177-188.
73. He ML, Chen Y, Peng Y, Jin D, Du D, Wu J, Lu P, Lin MC, Kung HF:
Induction of apoptosis and inhibition of cell growth by devel-
opmental regulator hTBX5.  Biochem Biophys Res Commun 2002,
297:185-192.
74. Jacobs JJ, Keblusek P, Robanus-Maandag E, Kristel P, Lingbeek M, Ned-
erlof PM, van Welsem T, van de Vijver MJ, Koh EY, Daley GQ, van
Lohuizen M: Senescence bypass screen identifies TBX2, which
represses Cdkn2a (p19(ARF)) and is amplified in a subset of
human breast cancers.  Nat Genet 2000, 26:291-299.
75. Sinclair CS, Adem C, Naderi A, Soderberg CL, Johnson M, Wu K,
Wadum L, Couch VL, Sellers TA, Schaid D, Slezak J, Fredericksen Z,
Ingle JN, Hartmann L, Jenkins RB, Couch FJ: TBX2 is preferentially
amplified in BRCA1- and BRCA2-related breast tumors.  Can-
cer Res 2002, 62:3587-3591.
76. Vance KW, Carreira S, Brosch G, Goding CR: Tbx2 is over-
expressed and plays an important role in maintaining prolif-
eration and suppression of senescence in melanomas.  Cancer
Res 2005, 65:2260-2268.
77. Barlund M, Monni O, Kononen J, Cornelison R, Torhorst J, Sauter G,
Kallioniemi OP, Kallioniemi A: Multiple genes at 17q23 undergo
amplification and overexpression in breast cancer.  Cancer Res
2000, 60:5340-5344.
78. Mahlamaki EH, Barlund M, Tanner M, Gorunova L, Hoglund M, Karhu
R, Kallioniemi A: Frequent amplification of 8q24, 11q, 17q, and
20q-specific genes in pancreatic cancer.  Genes Chromosomes
Cancer 2002, 35:353-358.
79. Lingbeek ME, Jacobs JJ, van Lohuizen M: The T-box repressors
TBX2 and TBX3 specifically regulate the tumor suppressor
gene p14ARF via a variant T-site in the initiator.  J Biol Chem
2002, 277:26120-26127.
80. Prince S, Carreira S, Vance KW, Abrahams A, Goding CR: Tbx2
directly represses the expression of the p21(WAF1) cyclin-
dependent kinase inhibitor.  Cancer Res 2004, 64:1669-1674.
81. Brummelkamp TR, Kortlever RM, Lingbeek M, Trettel F, MacDonald
ME, van Lohuizen M, Bernards R: TBX-3, the gene mutated in
Ulnar-Mammary Syndrome, is a negative regulator of
p19ARF and inhibits senescence.  J Biol Chem 2002,
277:6567-6572.
82. Carlson H, Ota S, Campbell CE, Hurlin PJ: A dominant repression
domain in Tbx3 mediates transcriptional repression and cell
immortalization: relevance to mutations in Tbx3 that cause
ulnar-mammary syndrome.  Hum Mol Genet 2001, 10:2403-2413.
83. Harrelson Z, Kelly RG, Goldin SN, Gibson-Brown JJ, Bollag RJ, Silver
LM, Papaioannou VE: Tbx2 is essential for patterning the atrio-
ventricular canal and for morphogenesis of the outflow tract
during heart development.  Development 2004, 131:5041-5052.
84. Cai CL, Zhou W, Yang L, Bu L, Qyang Y, Zhang X, Li X, Rosenfeld
MG, Chen J, Evans S: T-box genes coordinate regional rates of
proliferation and regional specification during cardiogenesis.
Development 2005, 132:2475-2487.
85. Schedl A, Ross A, Lee M, Engelkamp D, Rashbass P, van Heyningen V,
Hastie ND: Influence of PAX6 gene dosage on development:
overexpression causes severe eye abnormalities.  Cell 1996,
86:71-82.
86. Lehmann OJ, Ebenezer ND, Jordan T, Fox M, Ocaka L, Payne A, Leroy
BP, Clark BJ, Hitchings RA, Povey S, Khaw PT, Bhattacharya SS:
Chromosomal duplication involving the forkhead transcrip-
tion factor gene FOXC1 causes iris hypoplasia and glau-
coma.  Am J Hum Genet 2000, 67:1129-1135.
87. Zakin L, De Robertis EM: Inactivation of mouse Twisted gastru-
lation reveals its role in promoting Bmp4 activity during
forebrain development.  Development 2004, 131:413-424.
88. Liu J, Wilson S, Reh T: BMP receptor 1b is required for axon
guidance and cell survival in the developing retina.  Dev Biol
2003, 256:34-48.
89. Faber SC, Robinson ML, Makarenkova HP, Lang RA: Bmp signaling
is required for development of primary lens fiber cells.  Devel-
opment 2002, 129:3727-3737.
90. Dudley AT, Robertson EJ: Overlapping expression domains of
bone morphogenetic protein family members potentially
account for limited tissue defects in BMP7 deficient
embryos.  Dev Dyn 1997, 208:349-362.
91. Ohkubo Y, Chiang C, Rubenstein JL: Coordinate regulation and
synergistic actions of BMP4, SHH and FGF8 in the rostral
prosencephalon regulate morphogenesis of the telen-
cephalic and optic vesicles.  Neuroscience 2002, 111:1-17.
92. McLaughlin T, Hindges R, O'Leary DD: Regulation of axial pat-
terning of the retina and its topographic mapping in the
brain.  Curr Opin Neurobiol 2003, 13:57-69.
9 3 . O g i t a  J ,  I s o g a i  E ,  S u d o  H ,  S a k i y a m a  S ,  N a k a g a w a r a  A ,  K o s e k i  H :
Expression of the Dan gene during chicken embryonic devel-
opment.  Mech Dev 2001, 109:363-365.
94. Sakuta H, Suzuki R, Takahashi H, Kato A, Shintani T, Iemura S,
Yamamoto TS, Ueno N, Noda M: Ventroptin: a BMP-4 antago-
nist expressed in a double-gradient pattern in the retina.  Sci-
ence 2001, 293:111-115.
95. Take-uchi M, Clarke JD, Wilson SW: Hedgehog signalling main-
tains the optic stalk-retinal interface through the regulation
of Vax gene activity.  Development 2003, 130:955-968.
96. Zhang XM, Yang XJ: Temporal and spatial effects of Sonic
hedgehog signaling in chick eye morphogenesis.  Dev Biol 2001,
233:271-290.
97. Mui SH, Hindges R, O'Leary DD, Lemke G, Bertuzzi S: The homeo-
domain protein Vax2 patterns the dorsoventral and naso-
temporal axes of the eye.  Development 2002, 129:797-804.
98. Cockroft DL: Dissection and culture of postimplantation
embryos.  In Postimplantation Mammalian Embryos: A Practical
Approach Edited by: Copp AJ and Cockroft DL. Oxford, UK., IRL
Press at Oxford Univeristy Press; 1990:15–40.. 
99. Lee SH, Fu KK, Hui JN, Richman JM: Noggin and retinoic acid
transform the identity of avian facial prominences.  Nature
2001, 414:909-912.
100. Wilkinson DG: In situ hybridisation.  Oxford, Oxford University
Press; 1992. 